姜龙 博士 Jiang Long PHD. 浙江大学呼吸疾病研究所 Zhejiang University Respiratory Institute
中山大学临床医学博士,美国加州大学旧金山分校(UCSF)临床医学博士,浙江大学临床医学博士后,美国国立犹太健康中心Visiting Fellow。现任国际肺癌研究协会(IASLC)、偶走临床肿瘤协会(ESMO)、欧洲肿瘤免疫学会(EATI)会员;担任SCI杂志Transl Cancer Res、J Thorac Dis编委;并担任CANCER、INT J CANCER、ANN SURG ONCOL等12个SCI杂志的审稿人。
16:00 - 16:45
对于免疫和干细胞功能研究,我们开启了活细胞动力学测试的新时代
主讲人:David Ferrick, PH.D
安捷伦科技,细胞分析事业部高级总监
Dr. Ferrick has over 15 years of R&D Dr. Ferrick has over 15 years of R&D experience in drug discovery, clinical development and life science applications. As an industry executive he has transformed three biotechnology research platforms into product pipelines, founded one of those companies, raised over $20M in private equity and established several corporate alliances including Pfizer, Novartis and Boehringer Ingelheim.
16:45 - 17:15
新药监管模式下CAR-T细胞技术产业化的前景与挑战
杨林 教授 Dr. Yang Lin PHD.
苏州大学唐仲英血液学研究中心 Suzhou University Tang Zhong-Ying Hematology Research Center